Lir Life SciencesBBCMF -80.00%15 Shareholder Yield % is 1.59% as of Jan. 2026, which is 468% above its 10-year median of 0.28. GuruFocus rates BBCMF with a GF Score™ of 15/100. Among 1,303 Biotechnology companies, Lir Life Sciences ranks better than 81.2% on this metric.
Shareholder Yield % is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. It is a measure of shareholder return.
As of today, Lir Life Sciences's Shareholder Yield % was 1.59%.
Lir Life Sciences (OTCPK:BBCMF) Shareholder Yield % Explanation
Shareholder Yield % is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. The term was coined by William W. Priest of Epoch Investment Partners in a paper in 2005 entitled The Case for Shareholder Yield as a Dominant Driver of Future Equity Returns. William Priest indicated that "shareholder yield is a term that we came up with to reflect the various ways dividends can be paid to owners of a business in a publicly-traded company."
Dividend Yield % shows how much a company pays out in dividends each year relative to its stock price, which is most obvious form of shareholder return.
Buyback Yield % is the net repurchase of shares outstanding over the market capital of the company. Shares repurchases also increase shareholder value by returning the money back to shareholders.
Net Debt Paydown Yield % is the change in average of four quarters of company's total debt over a company's market cap. Assuming the total value of a company remains that same, shareholder value is increased as debt is reduced.
Lir Life Sciences Shareholder Yield % Related Terms
Lir Life Sciences Shareholder Yield % Historical Data
* Premium members only.
The historical data trend for Lir Life Sciences's Shareholder Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BBCMF vs VRTX, REGN, ALNY: Shareholder Yield % Comparison
For the Biotechnology subindustry, Lir Life Sciences's Shareholder Yield %, along with its competitors' market caps and Shareholder Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Lir Life Sciences Shareholder Yield % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Lir Life Sciences's Shareholder Yield % distribution charts can be found below:
* The bar in red indicates where Lir Life Sciences's Shareholder Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* All the data are calculated by TTM values. Note that if a companies is traded in several exchanges, then we calculate the company level data for Shareholder Yield % using the primary share class stock data. The calculation result in definition page is for demonstration purpose only, and it's showing the share class level data. Therefore, the numbers in the calculation may differ from elsewhere if the stock is not a primary share.
Lir Life Sciences (BBCMF) has a Shareholder Yield % of 1.59% as of Jan. 2026. Shareholder Yield is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. View historical data on Lir Life Sciences and its competitors. This is 468% above median its historical median of 0.28. Over the past decade, Lir Life Sciences' Shareholder Yield % has ranged from 0.28 to 1.59. According to the industry distribution chart, Lir Life Sciences ranks #245 out of 1303 companies in the Biotechnology industry, placing it in the top 18.8%.
Is Lir Life Sciences' Shareholder Yield % too high?
Lir Life Sciences' current Shareholder Yield % of 1.59% is 468% above median its 10-year median of 0.28. Over the past 10 years, this metric has ranged from a low of 0.28 to a high of 1.59. Based on the distribution chart, Lir Life Sciences ranks #245 out of 1303 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Lir Life Sciences has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does Lir Life Sciences' Shareholder Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Lir Life Sciences ranks #245 out of 1303 companies for Shareholder Yield %. This places Lir Life Sciences in the top 19% of its industry — outperforming the majority of peers. Historically, Lir Life Sciences' own Shareholder Yield % has ranged from 0.28 to 1.59 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shareholder Yield % for a Biotechnology company?
A good Shareholder Yield % depends on the Biotechnology industry context. However, Shareholder Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shareholder Yield % mean?
A high Shareholder Yield % can signal that a stock is expensive relative to its fundamentals. Shareholder Yield is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. View historical data on Lir Life Sciences and its competitors. Lir Life Sciences's current Shareholder Yield % is 1.59%, which is 468% above median its own 10-year median of 0.28. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lir Life Sciences stock overvalued right now?
Lir Life Sciences (BBCMF) has a current Shareholder Yield % of 1.59%. The current Shareholder Yield % is 1.59%, which is 468% above median its 10-year median of 0.28. Lir Life Sciences' overall GF Score™ is 15/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shareholder Yield % calculated?
Shareholder Yield % is calculated from a company's financial statements. For Lir Life Sciences (BBCMF), the current Shareholder Yield % is 1.59% as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Address505-1505 West 2nd Avenue, Vancouver, BC, CAN, V6J 1H2
Lir Life Sciences Corp is a biotechnology company developing transdermal and sublingual drug-delivery technologies for GLP-1-based obesity therapies, with the focus of improving accessibility and patient experience.
15GF Score
Get the complete analysis for BBCMF
Shareholder Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BBCMF has been successfully added to your 